Stock Snapshot

Market Snapshot

BSE Sensex: 57426.92 1.80%
BSE 500: 23642.46 1.57%
BSE 200: 7522.74 1.57%
BSE 100: 17574.98 1.57%
BSE Mid-Cap: 24853.94 1.39%
BSE Small-Cap: 28452.91 1.45%
BANKEX: 44179.79 2.63%
BSE IT Sector: 27488.42 0.82%
Nifty 50: 17094.35 1.64%
Nifty 500: 14829.35 1.55%
Nifty 200: 9147.45 1.58%
Nifty 100: 17438.6 1.58%
Nifty Midcap 100: 30668.3 1.60%
Nifty Small 100: 9441.8 1.59%
Nifty IT: 26981.15 0.60%
Nifty PSU Bank: 2995 3.01%

News:

Dilip Buildcon gains on emergi...
Dish TV India Ltd leads losers...
Akshar Spintex Ltd leads loser...
Goa Carbon temporarily shuts G...
Volumes spurt at Caplin Point ...

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Mid Cap

Invest

30 Sep 2022 | 03:59 PM

1,424.30

-21.35 (-1.48%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

-3.84%

Return (1Y)

Beaten S&P BSE Healthcare by 6.96%
More Volatile

1.62%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.56%
Consistent Performer

8/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,917

1,373

News & Announcements

Glaxosmithkline Pharmaceuticals consolidated net profit declines 1.49% in the June 2022 quarter
66 days ago

Glaxosmithkline Pharmaceuticals consolidated net profit declines 1.49% in the June 2022 quarter

26 - Jul - 2022 12:00 AM | 66 days ago

Net profit of Glaxosmithkline Pharmaceuticals declined 1.49% to Rs 119.28 crore in the quarter ended June 2022 as against Rs 121.08 crore during the previous quarter ended June 2021. Sales rose 3.72% to Rs 745.10 crore in the quarter ended June 2022 as against Rs 718.37 crore during the previous quarter ended June 2021.
Particulars Quarter Ended
Jun. 2022 Jun. 2021 % Var.
Sales 745.10 718.37 4
OPM % 19.99 18.48 -
PBDT 178.90 177.46 1
PBT 163.08 159.92 2
NP 119.28 121.08 -1
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals director resigns
67 days ago

Glaxosmithkline Pharmaceuticals director resigns

25 - Jul - 2022 12:00 AM | 67 days ago

Glaxosmithkline Pharmaceuticals announced the resignation of Nihal Kaviratne (Din:00032473) has voluntarily relinquished his position as Board member with effect from closing hours of 26 July 2022.
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to discuss results
93 days ago

GlaxoSmithKline Pharmaceuticals to discuss results

29 - Jun - 2022 12:00 AM | 93 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 July 2022.
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals director resigns
106 days ago

Glaxosmithkline Pharmaceuticals director resigns

16 - Jun - 2022 12:00 AM | 106 days ago

Glaxosmithkline Pharmaceuticals announced the resignation of Mark Dawson, Non Executive Director of the company with effect from 30 June 2022.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Glaxosmithkline Pharma Ltd is trading very close to its 52 Week Low
FII shareholding in Glaxosmithkline Pharma Ltd has increased by 33.8% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Jun. 2022	Jun. 2021	% Var.
Sales	745.10	718.37	4
OPM %	19.99	18.48	-
PBDT	178.90	177.46	1
PBT	163.08	159.92	2
NP	119.28	121.08	-1

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Mid Cap

1,424.30 -21.35 (-1.48%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Mid Cap

1,424.30

-21.35 (-1.48%)